Issue 7/2013
Content (12 Articles)
Immune-suppressive properties of the tumor microenvironment
Jürgen C. Becker, Mads Hald Andersen, David Schrama, Per thor Straten
Activation, dysfunction and retention of T cells in vaccine sites after injection of incomplete Freund’s adjuvant, with or without peptide
Elise P. Salerno, Sofia M. Shea, Walter C. Olson, Gina R. Petroni, Mark E. Smolkin, Chantel McSkimming, Kimberly A. Chianese-Bullock, Craig L. Slingluff Jr.
Efficient ex vivo induction of T cells with potent anti-tumor activity by protein antigen encapsulated in nanoparticles
Rodney A. Rosalia, Ana Luisa Silva, Marcel Camps, Ahmed Allam, Wim Jiskoot, Sjoerd H. van der Burg, Ferry Ossendorp, Jaap Oostendorp
Intratumoral injection of therapeutic HPV vaccinia vaccine following cisplatin enhances HPV-specific antitumor effects
Sung Yong Lee, Tae Heung Kang, Jayne Knoff, Zhuomin Huang, Ruey-Shyang Soong, Ronald D. Alvarez, Chien-Fu Hung, T.-C. Wu
Therapy model for advanced intracerebral B16 mouse melanoma using radiation therapy combined with immunotherapy
Henry M. Smilowitz, Daniel Sasso, Edward W. Lee, Gyuhyeong Goh, Peggy L. Micca, F. Avraham Dilmanian
Anti-metastatic potential of human Vδ1+ γδ T cells in an orthotopic mouse xenograft model of colon carcinoma
Christel Devaud, Benoît Rousseau, Sonia Netzer, Vincent Pitard, Christian Paroissin, Camille Khairallah, Pierre Costet, Jean-François Moreau, Franck Couillaud, Julie Dechanet-Merville, Myriam Capone
EBV-transformed lymphoblastoid cell lines as vaccines against cancer testis antigen-positive tumors
Frank Neumann, Dominic Kaddu-Mulindwa, Thomas Widmann, Klaus-Dieter Preuss, Gerhard Held, Carsten Zwick, Klaus Roemer, Michael Pfreundschuh, Boris Kubuschok
Analysis of surrogate gene expression markers in peripheral blood of melanoma patients to predict treatment outcome of adjuvant pegylated interferon alpha 2b (EORTC 18991 side study)
Antonia Busse, Jérôme Rapion, Alberto Fusi, Stefan Suciu, Anika Nonnenmacher, Mario Santinami, Wim H. J. Kruit, Alessandro Testori, Cornelis J. A. Punt, Angus G. Dalgleish, Alan Spatz, Alexander M. M. Eggermont, Ulrich Keilholz
Antibody-dependent cell lysis by NK cells is preserved after sarcoma-induced inhibition of NK cell cytotoxicity
Jens H. W. Pahl, S. Eriaty N. Ruslan, Kitty M. C. Kwappenberg, Monique M. van Ostaijen-ten Dam, Maarten J. D. van Tol, Arjan C. Lankester, Marco W. Schilham
Ex vivo analysis of pancreatic cancer-infiltrating T lymphocytes reveals that ENO-specific Tregs accumulate in tumor tissue and inhibit Th1/Th17 effector cell functions
Amedeo Amedei, Elena Niccolai, Marisa Benagiano, Chiara Della Bella, Fabio Cianchi, Paolo Bechi, Antonio Taddei, Lapo Bencini, Marco Farsi, Paola Cappello, Domenico Prisco, Francesco Novelli, Mario Milco D’Elios
A novel recombinant protein of IP10-EGFRvIIIscFv and CD8+ cytotoxic T lymphocytes synergistically inhibits the growth of implanted glioma in mice
Xuan Wang, Xiao-Ling Lu, Hong-Yang Zhao, Fang-Cheng Zhang, Xiao-Bing Jiang
Blocking retinoic acid receptor-α enhances the efficacy of a dendritic cell vaccine against tumours by suppressing the induction of regulatory T cells
Karen C. Galvin, Lydia Dyck, Neil A. Marshall, Anna M. Stefanska, Kevin P. Walsh, Barry Moran, Sarah C. Higgins, Lara S. Dungan, Kingston H. G. Mills